Expression of von Hippel-Lindau protein in normal and pathological human tissues

Histochemical Journal

Volumn 31, Issue 2, 1999, Pages 133-144

  Sakashita, Naomi ^a   Takeya, Motohiro ^a   Kishida, Takeshi ^b   Stackhouse, Thomas M ^c   Zbar, Berton ^c   Takahashi, Kiyoshi ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY;

ADOLESCENT; ADULT; AGED; AMINO ACID SEQUENCE; ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOELECTRON MICROSCOPY; MALE; NEOVASCULARIZATION (PATHOLOGY); NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR CELL LINE; VON HIPPEL LINDAU DISEASE; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; LIGASES; MALE; MICROSCOPY, IMMUNOELECTRON; MIDDLE AGED; NEOPLASMS; PROTEINS; TISSUE DISTRIBUTION; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 0033052893     PISSN: 00182214     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1003554712386     Document Type: Article

References (30)

1. Aso T, Lane WS, Conaway JW, Conaway RC (1995) Elongin (SIII): a multisubunit regulator of elongation by RNA polymerase II. Science 269: 1439-1443.
2. Baker SJ, Markowitz S, Fearon ER, Willson JK, Vogelstein B (1990) Suppression of human colorectal carcinoma cell growth by wild-type p53. Science (Washington DC) 249: 912-915.
3. Chen F, Kishida T, Duh FM, Renbaum P, Orcutt ML, Schmidt L, Zbar B (1995a) Suppression of growth of renal cell carcinoma cells by the von Hippel-Lindau tumor suppressor gene. Cancer Res 55: 4804-4807.
4. Chen F, Kishida T, Yao M, Hustad T, Glavac D, Dean D, Gnarra JR, Orcutt ML, Duh FM, Glenn GM, Green J, Hsia YE, Lamiell J, Li H, Wei MH, Schmidt L, Tory K, Kuzmin I, Stackhouse T, Latif F, Linehan WM, Lerman MI, Zbar B (1995b) Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype. Hum Mutat 5: 66-75.
5. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, Macdonald S, Pulford KA, Stein II, Mason DY (1984) Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32: 219-229.
6. Duan DR, Humphrey JS, Chen DYT, Weng Y, Sukegawa J, Lee S, Gnarra JR, Linehan WM, Klausner RD (1995a) Characterization of the VHL tumor suppressor gene product: Localization, complex formation, and the effect of natural inactivating mutations. Proc Natl Acad Sci USA 92: 6459-6463.
7. Duan DR, Pause A, Burgess WH, Aso T, Chen DYT, Garrett KP, Conaway RC, Conaway JW, Linehan WM, Klausner RD (1995b) Inhibition of transcription elongation by the VHL tumor suppressor protein. Science 269: 1402-1406.
8. Dvorak HF, Brown LF, Detmar M, Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146: 1029-1039.
9. Gnarra JR, Duan DR, Weng Y, Humphrey JS, Chen DY, Lee S, Pause A, Dudley CF, Latif F, Kuzmin I, Schmidt L, Duh FM, Stackhouse T, Chen F, Kishida T, Wei MH, Lerman MI, Zbar B, Klausner RD, Linehan WM (1996) Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal carcinoma. Biochim Biophys Acta 1242: 201-210.
10. Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Latif F, Liu F, Chen F, Duh F-M, Lubenski I, Duan DR, Florence C, Pozzatti R, Walther MM, Bander NH, Grossmann HB, Brauch H, Pomer S, Brook JD, Issacs WB, Lerman MI, Zbar B, Linehan WM (1994) Mutations of the VHL tumor suppressor gene in renal carcinoma. Nat Genet 7: 85-90.
11. Groden J, Joslyn G, Samowitz W, Jones D, Bhattacharyya N, Spirio L (1995) Response of colon cancer cell lines to the introduction of APC, a colon-specific tumor suppressor gene. Cancer Res 55: 1531-1539.
12. Haber DA, Park S, Maheswaran S, Englert C, Re GG, Hazen-Martin DL, Sens DA, Garvin AJ (1993) WT1-mediated growth suppression of Wilms tumor cells expressing a WT1 splicing variant. Science (Washington DC) 262: 2057-2059.
13. Hlatky L, Tsionou C, Hahnfeldt P, Coleman CN (1994) Mammary fibroblasts may influence breast tumor angiogenesis via hypoxia-induced vascular endothelial growth factor up-regulation and protein expression. Cancer Res 54: 6083-6086.
14. Huang HJS, Yee JK, Shew JY, Chen PL, Bookstein R, Friedmann T, Lee EYHP, Lee WH (1988) Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science (Washington DC) 242: 1563-1566.
15. Kishida T, Stackhouse TM, Chen F, Lerman MI, Zbar B (1995) Cellular proteins that bind the von Hippel-Lindau disease gene product: mapping of binding domains and the effect of missense mutations. Cancer Res 55: 4544-4548.
16. Kuzmin I, Duh FM, Latif F, Zbar B, Lerman MI (1995) Identification of the promotor of the human von Hippel-Lindau disease tumor suppressor gene. Oncogene 10: 2185-2194.
17. Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L, Schmidt L, Zhou F, Li H, Wei MH, Chen F, Glenn G, Choyke P, Walther MM, Weng Y, Duan DSR, Dean M, Glavic D, Richerds FM, Crossey PA, Ferguson-Smith MA, Paslier DL, Chumakov I, Cohen D, Chinault AC, Maher ER, Linehan WM, Zbar B, Lerman MI (1993) Identification of the von Hippel-Lindau disease tumor suppressor gene. Science (Washington DC) 260: 1317-1320.
18. Lee S, Chen DY, Humphrey JS, Gnarra JR, Linehan WM, Klausner RD (1996) Nuclear/cytoplasmic localization of the von Hippel-Lindau tumor suppressor gene product is determined by cell density. Proc Natl Acad Sci USA 93: 1770-1775.
19. Los M, Jansen GH, Kaelin WG, Lips CJM, Blijham GH, Voest EE (1996) Expression pattern of the von Hippel-Lindau protein in human tissues. Lab Invest 75: 231-238.
20. Morii K, Tanaka R, Washiyama K, Kumanishi T, Kuwano R (1993) Expression of vascular endothelial growth factor in capillary hemangioblastoma. Biochem Biophys Res Commun 194: 749-755.
21. Nagashima Y, Miyagi Y, Udagawa K, Taki A, Misugi K, Sakai N, Kondo K, Kaneko S, Yao M, Shuin T (1996) von Hippel-Lindau tumour suppressor gene. Localization of expression by in situ hybridization. J Pathol 180: 271-274.
22. Nomura M, Yamagishi S, Harada S, Hayashi Y, Yamashima T, Yamashita J, Yamamoto H (1995) Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes. J Biol Chem 270: 28316-28324.
23. Seizinger BR, Smith DI, Filling-Katz MR, Neumann H, Green JS, Choyke PL, Anderson KM, Freiman RN, Klauck SM, Whaley J, Decker HJH, Hsia YE, Collins D, Halperin J, Lamiell JM, Oostra B, Waziri MH, Gorin MB, Scherer G, Drabkin HA, Aronin N, Schinzel A, Martuza RL, Gusella JF, Haines JL (1991) Genetic flanking markers refine diagnostic criteria and provide insights into the genetics of von Hippel Lindau disease. Proc Natl Acad Sci USA 88: 2864-2868.
24. Siemeister G, Weindel K, Mohrs K, Barleon B, Martiny-Baron G, Marmé D (1996) Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein. Cancer Res 56: 2299-2301.
25. Takagi H, King GL, Atello LP (1996) Identification and characterization of vascular endothelial growth factor receptor (FIt) in bovine retinal pericytes. Diabetes 45: 1016-1023.
26. Walker C, Ahn YT, Everitt J, Yuan X (1996) Renal cell carcinoma development in the rat independent of alterations at the VHL gene locus. Mol Carcinog 15: 154-161.
27. Weinberg RA (1991) Tumor suppressor genes. Science 254: 1138-1146.
28. Whaley JM, Gablich J, Galbert L, Hsia E, Lamiell JM, Green JS, Collins D, Neumann HPH, Laidlaw J, Li FP, Klein-Szanto AJP, Seizinger BR, Kley N (1994) Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma. Am J Hum Genet 55: 1092-1102.
29. Wizigmann-Voos S, Breier G, Risau W, Plate KH (1995) Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas. Cancer Res 55: 1358-1364.
30. Yamashiro S, Takeya M, Nishi T, Kuratsu J, Yoshimura T, Ushio Y, Takahashi K. (1994) Tumor-derived monocyte chemoattractant protein-1 induces intratumoral infiltration of monocyte-derived macrophage subpopulation in transplanted rat tumors. Am J Pathol 145: 856-867.